-
Reasons for rejection of section 18A Authority for medicinal cannabis
Since April 2021 60 applications for s18A authority to prescribe medicinal cannabis have been
refused:
• The majority (55) of applications were refused because further information requested was
not provided.
Joint Committees
55th Parliament
-
Strict regulation is also
required in relation to the advertising and promotion of medicinal cannabis products to prevent
commercialisation of the cannabis industry.
Joint Committees
55th Parliament
-
… The Bedrocan Cannabis Flos cannot be distinguished from illicit
cannabis.
Joint Committees
55th Parliament
-
… The Bedrocan Cannabis Flos cannot be distinguished from illicit
cannabis.
Joint Committees
55th Parliament
-
MedTEC Pharma’s Response to the South Australian Joint Committee on the
Legalisation of Medicinal Cannabis
Page 1 of 8
1.
Joint Committees
55th Parliament
-
What are the physical health risks of using cannabis?
Joint Committees
55th Parliament
-
Other people
make a difficult decision to go without medicinal cannabis so they can drive, despite
experiencing significant benefits from using the prescribed cannabis.
5.
Joint Committees
55th Parliament
-
Studies on the Reliability of THC as a Biomarker of Impairment in Cannabis Users:
Introduction: THC (delta-9-tetrahydrocannabinol) is the main psychoactive compound found in cannabis,
and it is the primary target for drug testing in order to determine impairment in cannabis users.
Joint Committees
55th Parliament
-
Cannabis guilty.
Joint Committees
55th Parliament
-
General - Taking of Cannabis Samples
Presented by
Hon Dr Jane Lomax-Smith AM
on
28/10/2008
